Tokyo, Japan

Kazuki Hemmi

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Shizuoka, JP (2012)
  • Tokyo, JP (2014)
  • Sunto-gun, JP (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuki Hemmi: Innovator in Pharmaceutical Chemistry

Introduction

Kazuki Hemmi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 3 patents to his name, Hemmi's work focuses on addressing skin diseases through novel chemical derivatives.

Latest Patents

One of Hemmi's latest patents involves a pyrazolopyrimidine derivative, which is designed to prevent and treat skin diseases. The invention provides a pyrazolopyrimidine derivative of a specific formula, where various components represent different chemical groups. This derivative can be used in a medicament aimed at treating skin conditions, showcasing Hemmi's commitment to advancing medical science.

Career Highlights

Kazuki Hemmi is currently employed at Kyowa Hakko Kirin Co., Limited, a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on innovative research and development, contributing to the advancement of therapeutic agents.

Collaborations

Hemmi collaborates with notable colleagues, including Seiji Aratake and Keisuke Yamamoto. Their combined expertise enhances the research efforts at Kyowa Hakko Kirin Co., Limited, fostering an environment of innovation and discovery.

Conclusion

Kazuki Hemmi's contributions to pharmaceutical chemistry, particularly in the development of treatments for skin diseases, highlight his role as an influential inventor. His ongoing work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…